Douglas Shemin - Concepedia

Author

Douglas Shemin

Also Known As

D G Shemin, D SHEMIN, D Shemin, D. Shemin, DOUGLAS SHEMIN, Douglas G. Shemin, Douglas Shemin, Shemin D, Windsor, Sheryl L

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Rhode Island Hospital Brown University Providence College Memorial Hospital of Rhode Island Tufts Medical Center

About

Douglas Shemin is an author at Rhode Island Hospital specializing in nephrology, medicine, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	2K
2	Health Sciences	3	3	369
3	Public Health	2	2	52
4	Blood Transplantation	2	2	55
5	Biochemistry	1	1	56

Douglas Shemin

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial Michael Böhm, Kazuomi Kario, David E. Kandzari, The Lancet Antihypertensive MedicationsHypertensionUrologyRenal FunctionAntihypertensive Therapy	2020	555
Residual renal function and mortality risk in hemodialysis patients Douglas Shemin, Andrew G. Bostom, Priscilla Laliberty, American Journal of Kidney Diseases HemodialysisUrologyRenal DiseaseMedicineKidney Failure	2001	312
Elevated Fasting Total Plasma Homocysteine Levels and Cardiovascular Disease Outcomes in Maintenance Dialysis Patients Andrew G. Bostom, Douglas Shemin, Petra Verhoef, Arteriosclerosis Thrombosis and Vascular Biology	1997	294
High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients Andrew G. Bostom, Douglas Shemin, Kate L. Lapane, Kidney International HemodialysisKidney FailureChronic Kidney DiseaseClinical NutritionHematology	1996	240
Complications of therapeutic plasma exchange: A prospective study of 1,727 procedures Douglas Shemin, Doris Briggs, Melanie Greenan Journal of Clinical Apheresis	2007	231
Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study Andrew G. Bostom, Douglas Shemin, Kate L. Lapane, Atherosclerosis	1995	173
Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients Douglas Shemin, Donna Maaz, Donna St. Pierre, American Journal of Kidney Diseases HemodialysisUrologyRenal DiseaseRenal FunctionMedicine	1999	119
Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients Andrew G. Bostom, Douglas Shemin, Kate L. Lapane, Atherosclerosis HemodialysisRenal FunctionMedicineKidney FailureFolate Status	1996	115
Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study Andrew G. Bostom, Douglas Shemin, Kate L. Lapane, Atherosclerosis Metabolic SyndromeHemodialysisUrologyRenal DiseaseHypertension	1996	114
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications David E. Kandzari, Raymond R. Townsend, Kazuomi Kario, Journal of the American College of Cardiology	2023	93

Page 1